FDA NOTE The Coalition for Healthcare Communication (CHC) has released a position paper proposing new Food and Drug Administration guidelines for company dissemination of off-label (uses unapproved by the FDA) drug information. Recently, the U.S. District Court for the District of Columbia found that existing FDA guidelines and related provisions of the FDA Modernization Act are unconstitutional. The FDA has appealed the court's decision. The Coalition position paper emphasizes that the ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.